Commercial Manufacturing

Covering a 135,000ft² area, our Miami facility is registered with the FDA and complies fully with current good manufacturing practice (cGMP) guidelines. It has the capacity for R&D, process development and small-scale launches, including pilot-scale cGMP manufacturing and packaging to support pilot pharmacokinetic (PK) studies. The facility offers a full selection of oral solid dosage forms, including modified release dosage forms and enteric-coated tablets. It can produce extended-release tablets using both wet and dry granulation techniques, and design drug delivery systems for poorly soluble compounds. PLD Pharma Services has the capacity to produce up to six billion tablets and capsules a year, as well as a wide range of products for both oral dose and liquid dose, including small-volume, high-potency compounds and small-molecule compounds